Objective Lymphoscintigraphy (LS) and sentinel lymph node biopsy have become the standard of care for melanoma and breast cancer. However, the data on patients with cutaneous squamous cell carcinoma (SCC) are limited. We aimed to evaluate and identify the role of LS and sentinel lymph node biopsy in patients with high-risk cutaneous SCC.
Objective Lymphoscintigraphy (LS) and sentinel lymph node biopsy have become the standard of care for melanoma and breast cancer. However, the data on patients with cutaneous squamous cell carcinoma (SCC) are limited. We aimed to evaluate and identify the role of LS and sentinel lymph node biopsy in patients with high-risk cutaneous SCC.
Methods Nineteen patients (13 men, six women; 47-87 years of age, mean age 67.5 ± 12.3) with SCC were included in the study. LS was performed on all patients after intracutaneous injection of Tc-99m nanocolloid. Primary lesions and sentinel lymph nodes (SLNs) were excised with the help of a gamma probe.
Results A total of 26 SLNs and 32 secondary lymph nodes were imaged on LS and were marked. During surgery, 29 SLNs, 21 secondary lymph nodes and three nonactive lymph nodes were excised. In total, 53 lymph nodes were removed surgically. A histopathological study revealed that all lymph nodes were negative for metastasis. Patients were followed up for an average of 41.1 ± 22.2 months (7-80 months). Until the time of data collection, 14 patients were alive and had no regional lymph node or distant metastasis. Local recurrence was seen in only one patient. He was reoperated upon 38 months ago.
Conclusion
The feasibility of determining SLNs using LS and an intraoperative gamma probe in patients with cutaneous SCC was shown. 
Introduction
Squamous cell carcinoma (SCC) is the second most common type of skin cancer after basal cell carcinoma.
The tumour typically appears as a papule or nodule, with varying degrees of hyperkeratosis and ulceration that arise on the sun-exposed skin of elderly patients [1] . Although SCC is usually easily treatable, it has the potential to recur locally and even metastasize, leading to significant morbidity and mortality. Therefore, it is important to identify those tumours that are more aggressive and require closer followup and possible adjunctive treatments such as micrographic surgery, lymphadenectomy or radiation therapy [1] .
The presence of regional lymph node metastasis is the most powerful prognostic factor for predicting recurrence and survival in patients with most solid tumours [2] . The exact rate of lymph node metastasis remains uncertain, and several papers have suggested significant variation in the risk of metastatic spread (from 0.3 to 20.7%) [3] . However, depending on patient and tumour characteristics, there are subgroups of patients with higher risk. Tumour size (> 2 cm) and location (face, especially in lips or ear), locally recurrent SCC or arising on chronically diseased skin, poorly differentiated histological subtype, perineural invasion, a depth of more than 4 mm, Clark's level IV or V, involvement of the reticular dermis or subcutaneous fat or penetration into muscle, bone or cartilage and immunosuppression of the patient are major risk factors for metastasis [4] . Metastasis rates can reach up to 30% for lesions more than 2 cm in diameter [5] .
Lymphatic mapping and sentinel lymph node biopsy (SLNB) procedures using different techniques such as blue dye, a gamma probe, or a combination of both have become the standard procedures for melanoma and breast cancer [6] [7] [8] [9] [10] . Some previous studies emphasized the use of lymphoscintigraphy (LS) and SLNB in patients with genital and head and neck SCC [11] [12] [13] [14] [15] [16] [17] . However, there were a few previous reports that underlined the use of SLNB in patients with cutaneous SCC [18] [19] [20] [21] . Considering these results, the aim of this study was to identify the role of LS and SLNB in patients with highrisk cutaneous SCC.
Methods

Patients
A total of 19 patients with high-risk cutaneous SCC were included in this prospective study. The criteria used to determine high-risk SCC included tumours located on the ear, scalp, nose, temple, dorsum of the hands and cutaneous aspects of the lips. Tumour size greater than 2 cm, depth of invasion greater than 4 mm, grade 2 differentiation or greater, perineural invasion and recurrent tumours were also regarded as high-risk characteristics. SLNB was not performed in patients who had clinical or radiological evidence of regional lymph node metastases. Patients with previous lymphadenectomy and pregnant and breastfeeding women were also excluded from the study. The study was approved by the institutional ethical committee, and written informed consent was obtained from all participating patients.
Lymphoscintigraphy
All patients underwent preoperative LS to identify the approximate number and location of sentinel lymph nodes (SLNs). LS was performed after intradermal injection of 100 mCi Tc-99m nanocolloid into three to four quadrants around the primary lesion or previous biopsy scar. Dynamic images (15 s/frame, in a 64 Â 64 matrix) up to 30 min and late static images (5 min in a 256 Â 256 matrix) were obtained using a single-head gamma camera SPECT system (ADAC Laboratories, Milpitas, California, USA) equipped with a low-energy, high-resolution collimator. A 20% window around the 140 keV energy peak of Tc-99m was used. According to the dynamic images, any lymph node that received lymph drainage directly from a tumour site was considered as an SLN (Figs 1-4). Other active lymph nodes were considered as secondary lymph nodes. Lymph channels from the tumour site to the lymph nodes could be easily visible using fast dynamic imaging. However, in some cases, lymph channels could not be imaged so easily. In this situation, the first apparent lymph node or nodes were considered as SLNs (Fig. 2) . Sometimes, no lymph nodes could be shown on dynamic image sets. Follow-up static images up to 1-2 h were very useful for determining SLN in such cases (Fig. 3 ). SLN and secondary lymph nodes were marked using an inerasable dye on the skin with the help of LS and a gamma probe (Crystal Probe 2000, Berlin, Germany). No significant complication was observed during or after LS.
Operation and intraoperative use of a gamma probe
Before surgery, all scintigraphic images of the patients were shown and discussed with the surgeons. Sentinel and secondary lymph nodes marked on the skin of the patients were also marked on the scintigraphic images. With this method (better knowledge for surgeons regarding LS images), concordance of LS mapping and dissection of lymph nodes (sentinel or secondary) using an intraoperative gamma probe was possible more easily.
After LS, all patients were taken to the operating room for complete excision of the primary tumour under general anaesthesia. Using a hand-held gamma probe (Crystal Probe 2000), hot lymph nodes with sufficient ratios of radioactivity compared with the background (more than 3 : 1 in vivo) or compared with neighbouring non-SLNs (more than 10 : 1 ex vivo) were excised. In addition, lymph nodes that were nonradioactive but suspicious for metastasis or that were more than 1 cm were also excised.
There was no major or minor complication during or after surgery. After operation, patients were followed up periodically for local recurrence, regional lymph nodes, or distant metastasis.
Pathology
In the routine histopathological procedure, the removed SLNs were fixed in formalin for 24 h. Lymph nodes with a A 58-year-old man (patient 16 in Table 1 ) had a lower lip lesion. Two submental sentinel lymph nodes were marked on the skin (arrows) (a). Two submental sentinel lymph nodes (open arrows) were seen easily in the late static image (b).
transverse diameter of less than 5 mm were embedded in paraffin as a whole, and lymph nodes larger than 5 mm were cut through the central cross-section into equal halves. We have planned to re-examine the SLNs once again to determine whether we have missed any tumour deposits in the residual lymph node tissue. The lymph nodes were step-sectioned at 250-mm intervals. Each layer was stained with haematoxylin and eosin (Fig. 5) . The sections were then stained with cytokeratin (CK1) (Fig. 5) .
Results
A total of 19 patients (13 men, six women; 47-87 years of age, mean age 67.5 ± 12.3) with high-risk SCC but without regional lymph node metastasis were included in the study. Primary lesions were found in the head in 14 patients (lips, five; scalp, four; ears, three; nose, one; and face, one) and in the extremities in five patients (lower, three; upper, two) ( Table 1 ). Three of them had bilateral SLNs (patients 5, 13 and 17 in Table 1 ). Interestingly, one patient had a primary lesion on the dorsum of the left hand. LS revealed two separate SLNs in the axilla and the supraclavicular region in this patient (patient 18 in Table 1 , Fig. 4 ).
Patients were followed up for an average of 41.1 ± 22.2 months (7-80 months). During this period, five patients died because of cardiac (four out of five) and traumatic (one out of five) events. Until the time of data collection, 14 patients were alive and had no regional lymph node or distant metastasis (Table 1) . Local recurrence was seen in only one patient after 31 months from the first operation. He was reoperated upon 38 months ago and was alive until the time of data collection.
Discussion
Regional lymph node metastasis is one of the most important prognostic factors in cancer patients. Although the incidence of lymphatic metastasis is relatively low in SCC (0.3-20.7%), it can be as high as 30% in patients with high-risk disease [3] . Management of SCC includes excision of the primary lesion and regional lymph node dissection (LD) in case of lymphatic metastasis while carrying out palpation and/or ultrasonography or other A 58-year-old man (patient 12 in Table 1 ) had a primary lesion on the scalp in the left frontal region. No sentinel lymph nodes could be seen in the dynamic images. In the follow-up static late images, one left preauricular sentinel lymph node was determined (arrow). A 78-year-old man (patient 1 in Table 1 ) had a primary lesion in the popliteal region. Lymphatic channels from the lesion to the lymph nodes could not be seen easily in the dynamic images. The first apparent lymph node was considered as the sentinel lymph node (arrow). An 87 year-old woman (patient 18 in Table 1 ) had a primary lesion on the dorsum of the left hand. Dynamic and late static lymphoscintigraphy images (a and b) revealed two separate sentinel lymph nodes (arrows) in the left supraclavicular and left axillary regions. Both lymph nodes were considered as sentinel because separate lymph channels from the tumour site to the lymph nodes were seen in the dynamic images.
radiological methods. However, palpation and/or other radiological evaluations cannot always determine disease in lymph nodes microscopically. Therefore, in patients with high-risk disease, elective LD is also one of the treatment options. However, this treatment approach also has some disadvantages. It will probably be an unnecessary procedure in a significant number of patients and may cause some morbid or mortal complications, including lymph oedema, infection and haematoma. Furthermore, prolonged operations and extended recovery period can also significantly increase the cost of treatment. Considering these factors, SLNB may be an important management choice in patients with high-risk SCC.
Some previous reports touched upon the usefulness of LS and SLNB in genital and head and neck SCC [11] [12] [13] [14] [15] [16] [17] . However, only a few previous reports that underlined the use of SLNB in patients with cutaneous SCC were published [18] [19] [20] [21] . Civantos et al. [18] reported the results of SLNB in 106 patients. In this study, the patient population, including that of oral and cutaneous SCC and malignant melanoma, was not homogeneous, and only 10 patients with cutaneous SCC were reported in this serial. Lymph node metastasis was detected in only one patient. In a recent study, Rastrelli et al. [20] reported preliminary results of SLNB in 20 cutaneous SCC patients. Similar to the previous study, nodal metastasis was detected in only one patient. Verifying these results, no patient had nodal metastasis in our study. The absence of positive lymph nodes in this study can be attributed to the relatively small number of participants. Because of the absence of any metastasis in lymph nodes in this cohort of patients, the necessity for SLNB seems to be controversial. As mentioned before, the management of cutaneous SCC includes two end points: (a) regional LD along with primary lesion dissection; and (b) elective regional LD because of lymph node metastasis after a certain followup period. Both management options have some disadvantages (overtreatment or insufficient treatment). However, SLNB is considered a minimally invasive surgical procedure. Therefore, the major potential contributions of SLNB for this cohort of patients are as follows: (a) avoidance of a stressful waiting period for appearance of regional lymph node metastasis; (b) avoidance of unnecessary LD and its potential risks and complications; (c) early diagnosis of microscopic or macroscopic lymph node metastasis in node-negative patients (clinical or radiological); and (d) detection and evaluation of unexpected lymph node basins.
The definition of an SLN has been approved as follows: 'A SLN is any lymph node which receives lymph drainage directly from a tumour site [22, 23] '. The biggest, the nearest to the primary tumour, or the most active lymph node on scintigraphy has not been accepted as an SLN. Therefore, dynamic scintigraphy has been considered the most important complement of SLNB procedures. It allows clinicians to find the exact SLN more easily and accurately. We also used dynamic scintigraphy in this study. According to the dynamic images, any lymph node Pathological examination of the first patient. H&E of the primary lesion (a), sentinel lymph node H&E (b) and CK1 (c). There was no macrometastasis or micrometastasis in the sentinel lymph node. H&E, haematoxylin and eosin.
that received lymph drainage directly from a tumour site was considered an SLN. Other active lymph nodes were considered as secondary lymph nodes. Lymph channels from the tumour site to the lymph nodes were easily visible using fast dynamic imaging. However, in some cases, lymph channels could not be imaged so easily. In such cases, the first apparent lymph node or nodes were considered as SLNs. Sometimes, no lymph nodes could be shown on dynamic image sets. Follow-up static images up to 1-2 h were very useful for determining SLNs in such cases. Eventually, it could be concluded that scintigraphy (dynamic or follow-up static images) is the most important part of the SLNB procedure.
Scintigraphy was also very useful in mid-line or near midline lesions because lymphatic drainage could reach both sites of the body. Six patients had mid-line or near midline lesions in this study. Three of them had bilateral SLNs. Also, lymphoscintigraphic mapping studies conducted in patients with cutaneous malignancies have been found to be discordant with clinically predicted drainage patterns in 60-80% of patients [24] [25] [26] . According to previous reports, any planned nodal dissection performed in the management of a cutaneous malignancy of the head and neck should be preceded by lymphoscintigraphic mapping [24] [25] [26] . In this study, one patient had a primary lesion on the dorsum of the left hand. LS revealed two separate SLNs in the axilla and the supraclavicular region. Axilla is considered the primary lymphatic basin of the upper extremity lesions. Also, lymphatic drainage to the supraclavicular region can be expected. However, an elective LD without preoperative lymphatic mapping could skip any supraclavicular lymph nodes.
We encountered some difficulties in patients with midline lesions while marking SLNs on the skin using scintigraphy or a gamma probe because of the 'shine through effect' of contralateral lymph nodes. Moreover, in patients with primary lesions in lips, gamma rays from the primary lesion could block the SLN. In such a case, we used small lead sheets to solve this problem.
During the follow-up period, no local recurrences, lymph nodes or distant metastases were observed. The mean follow-up period of our study was adequate to determine the false-negative rate of the procedure (41.1 ± 22.2 months, range 7-80 months) because local recurrences generally occur within 2 years after the operation [4, 19, 27] .
In conclusion, the feasibility of determining SLNs using LS and an intraoperative gamma probe in patients with cutaneous SCC was shown in this study. With this technique, unnecessary elective LD and possible complications could be avoided in 19 patients. With an adequate follow-up period, the absence of false negative results of the procedure was also demonstrated. LS and preoperative lymphatic mapping are the most important parts of SLNB.
The absence of positive lymph nodes in our study can be attributed to the relatively small number of participants. Therefore, further prospective, randomized, comparative studies with a larger number of patients for verifying the results of our study are necessary. With these investigations, the beneficial effect of early detection and treatment of subclinical (microscopic) lymph node metastasis in high-risk SCC patients could be determined more accurately.
